Mark J. Alles, Director at Turning Point Therapeutics, Inc. (TPTX), bought 2,000 shares at $81.34 ($163K) on 2021-06-21, disclosed to the SEC on 2021-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CELG | BUY | 2018-05-17 | $200K | — | Filing → |
| CELG | BUY | 2018-02-08 | $300K | — | Filing → |
| CELG | SELL | 2015-02-10 | $14.1M | — | Filing → |